Home RxNorm 2167163 cutaquig 16.5 % (4 GM in 24 ML) Injection Drug identity information. FDA.report links public drug records from RxNav, DailyMed, FDA NDC, Drugs@FDA, and related public sources where available. This page is informational only and is not medical, prescribing, or regulatory advice.
RxCUI 2167163
RxNorm name cutaquig 16.5 % (4 GM in 24 ML) Injection
Display name cutaquig 16.5 % (4 GM in 24 ML) Injection
Full name cutaquig 16.5 % (4 GM in 24 ML) Injection
Term type PSN
Status DailyMed mapping
Updated 2026-06-04 23:39:27 Purple Book Biologic Products# BLA, Proprietary name, Proper name table BLA Proprietary name Proper name License type Status Latest source 125668 Cutaquig Immune Globulin Subcutaneous (Human)-hipp 351(a) Rx 2026-08-01
RxNav Current And Historical NDCs# RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.
No records found.
UNII Substances# UNII substance links page 1 of 1 · 0 matching rows.
No records found.
DailyMed RxNorm Mappings# unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 2 matching rows.
Set ID, RxNorm mappings, Terms table Set ID RxNorm mappings Terms SPL version Label Effective f199187a-de4e-2047-0aee-b6d93390b3d2 cutaquig 16.5 % (4 GM in 24 ML) Injection [PSN] · 24 ML immune globulin subcutaneous (human) - hipp 165 MG/ML Injection [Cutaquig] [SBD] · 24 ML Cutaquig 165 MG/ML Injection [SY] · cutaquig 16.5 % (4 GM per 24 ML) Injection [SY] 4 15 These highlights do not include all the information needed to use CUTAQUIG safely and effectively. See full prescribing information for CUTAQUIG. CUTAQUIG® (Immune Globulin Subcutaneous (Human) - hipp), 16.5% solution Initial U.S. Approval: 2018 20250324 f3de095f-791a-85dc-7a14-ec7790cb13aa cutaquig 16.5 % (4 GM in 24 ML) Injection [PSN] · 24 ML immune globulin subcutaneous (human) - hipp 165 MG/ML Injection [Cutaquig] [SBD] · 24 ML Cutaquig 165 MG/ML Injection [SY] · cutaquig 16.5 % (4 GM per 24 ML) Injection [SY] 4 13 These highlights do not include all the information needed to use CUTAQUIG safely and effectively. See full prescribing information for CUTAQUIG. CUTAQUIG® (Immune Globulin Subcutaneous (Human) - hipp), 16.5% solution Initial U.S. Approval: 2018 20211130